288 related articles for article (PubMed ID: 16462303)
1. Primary lung abscess caused by multidrug-nonsusceptible Streptococcus pneumoniae in a child.
Holston AM; Miller JR
Pediatr Infect Dis J; 2006 Feb; 25(2):182-3. PubMed ID: 16462303
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand.
Srifuengfung S; Tribuddharat C; Champreeda P; Daniels J; Chokephaibulkit K; Wongwan N; Polwichai P
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):461-6. PubMed ID: 18564685
[TBL] [Abstract][Full Text] [Related]
4. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
Fogarty C; Goldschmidt R; Bush K
Clin Infect Dis; 2000 Aug; 31(2):613-5. PubMed ID: 10987733
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pneumococcal pneumonia.
Pallares R
Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
[TBL] [Abstract][Full Text] [Related]
6. Question 3: can pneumonia caused by penicillin-resistant Streptococcus pneumoniae be treated with penicillin?
Clifford V; Tebruegge M; Vandeleur M; Curtis N
Arch Dis Child; 2010 Jan; 95(1):73-7. PubMed ID: 20040690
[No Abstract] [Full Text] [Related]
7. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
8. Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004).
Draghi DC; Jones ME; Sahm DF; Tillotson GS
Int J Antimicrob Agents; 2006 Dec; 28(6):525-31. PubMed ID: 17101260
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal pneumonia in adults treated at University of Kentucky Medical Center, 1995-1998: implications of pathogen resistance.
Greenberg RN; Martin E
Clin Infect Dis; 1999 May; 28(5):1160-2. PubMed ID: 10452654
[No Abstract] [Full Text] [Related]
10. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.
Tan TQ; Mason EO; Barson WJ; Wald ER; Schutze GE; Bradley JS; Arditi M; Givner LB; Yogev R; Kim KS; Kaplan SL
Pediatrics; 1998 Dec; 102(6):1369-75. PubMed ID: 9832571
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
Zhanel GG; Wang X; Nichol K; Nikulin A; Wierzbowski AK; Mulvey M; Hoban DJ
Int J Antimicrob Agents; 2006 Nov; 28(5):465-71. PubMed ID: 17049211
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Lee WK; Young BW
J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
[No Abstract] [Full Text] [Related]
14. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
16. The association between antibiotic use in the community and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Bedouin children.
Greenberg D; Givon-Lavi N; Sharf AZ; Vardy D; Dagan R
Pediatr Infect Dis J; 2008 Sep; 27(9):776-82. PubMed ID: 18645545
[TBL] [Abstract][Full Text] [Related]
17. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure.
Jacobs MR
Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130
[No Abstract] [Full Text] [Related]
18. [New quinolones for the treatment of community-acquired pneumonia--contra].
Egger M
Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860
[No Abstract] [Full Text] [Related]
19. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
20. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona.
Muñoz-Almagro C; Esteva C; de Sevilla MF; Selva L; Gene A; Pallares R
J Infect; 2009 Aug; 59(2):75-82. PubMed ID: 19576637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
